Company Filing History:
Years Active: 2013-2015
Title: Innovations of Dange Vijay Kumar
Introduction
Dange Vijay Kumar is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel inhibitors for treating various medical conditions. With a total of three patents to his name, his work has the potential to impact the treatment of thromboembolic disorders, cancer, and rheumatoid arthritis.
Latest Patents
Dange Vijay Kumar's latest patents focus on Factor VIIa inhibitors. These inventions relate to novel inhibitors of Factors VIIa, IXa, Xa, and XIa, with a particular emphasis on Factor VIIa. The patents describe pharmaceutical compositions that comprise these inhibitors and methods for using them to treat or prevent thromboembolic disorders, cancer, or rheumatoid arthritis. Additionally, the patents disclose processes for preparing these inhibitors, showcasing his innovative approach to addressing critical health issues.
Career Highlights
Dange Vijay Kumar is currently associated with Pharmacyclics, Inc., where he continues to advance his research and development efforts. His work at this company highlights his commitment to improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include Daniel A Dickman and Colin O'Bryan. Their collaboration contributes to a dynamic research environment that fosters innovation and the development of new therapeutic options.
Conclusion
Dange Vijay Kumar's contributions to the field of pharmaceuticals through his patents and work at Pharmacyclics, Inc. demonstrate his dedication to advancing medical science. His innovative inhibitors have the potential to significantly improve treatment options for various serious health conditions.